Statements and Testimony

The ASM signed onto a letter sent to House and Senate appropriations committee leaders calling on Congress to increase the fiscal 2018 302(b) subcommittee allocations for Labor-HHS.
ASM joined the Infectious Diseases Society of America (IDSA) and the Pan American Society for Clinical Virology (PASCV) in drafting comments for the draft Diagnostic Accuracy and Innovation Act (DAIA) legislation.  The DAIA builds upon previous efforts to establish a new framework for the regulation of both in vitro diagnostic…
The ASM submitted funding recommendations for the Department of Defense for FY 2018 to Congress.
The ASM submitted funding recommendations for the Department of Energy Office of Science for FY 2018 to Congress.
ASM activities on Capitol Hill in support of agricultural research.
The ASM signed onto a letter to Congress urging completion the FY 2017 appropriations process with robust investments in scientific research.
The ASM submitted funding recommendations for the US Department of Agriculture for FY 2018 to Congress.
The ASM submitted funding recommendations for the National Science Foundation for FY 2018 to Congress.
The ASM submitted funding recommendations for the Food and Drug Administration for FY 2018 to Congress.
The ASM sent a statement to members of Congress urging support for funding growth for biomedical research, science and public health programs. 
ASM and the Pan American Society of Clinical Virology (PASCV) drafted a letter expressing concerns about the turnaround time for results in the Zika plaque reduction neutralizing test (PRNT) currently available and suggested some solutions.   
The ASM signed onto a letter to Mr. António Guterres, United Nations Secretary-General and Dr. Margaret Chan, World Health Organization Director-General regarding the progress since the political declaration of the high level meeting on antimicrobial resistance (AMR) in the United Nations (UN) General Assembly in September 2016.
The ASM signed on to a letter to President Trump regarding the essential role of the federal public health and biomedical research workforce as long-term policy regarding federal hiring is considered.
The ASM submitted funding recommendations for the National Institutes of Health for FY 2018 to Congress. 
The ASM submitted funding recommendations for the Centers for Disease Control and Prevention for FY 2018 to Congress. 
The ASM sent a letter to Senator Lamar Alexander (R-TN), chair and Senator Patty Murray (D-WA), ranking member of the Senate's health committee and Representative Greg Walden (R-OR), chair and Representative Frank Pallone Jr. (D-NJ), ranking member of the House Energy & Commerce Committee, and Texas Reps. Michael Burgess (R)…
Effective October 2016, the Centers for Disease Control and Prevention added Bacillus cereus biovar anthracis as a Tier 1 select agent to the list of select agents and toxins. Sentinel laboratories should continue using the existing ASM Sentinel Level Clinical Laboratory Guidelines for Suspected Agents of Bioterrorism and Emerging Infectious…
Thursday, 09 February 2017 12:59

Coalition Letter Supporting Biomedical Research

The ASM signed onto a letter to President Trump and Congressional leadership, urging the completion of an FY 2017 spending package that includes $34.1 billion for the National Institutes of Health (NIH). The letter was signed by 260 patient, medical, scientific, academic, and research organizations.
Tuesday, 07 February 2017 13:54

Coalition Letter Supporting Vaccine Safety

The ASM joined over 350 organizations in a letter to President Donald Trump expressing support for the safety of vaccines. 
On January 31, the ASM sent a letter to the president regarding the potential consequences travel bans could have on both U.S. and global scientific communities.
Page 2 of 3

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

113